CIK 0000899460
- Large accelerated filer
MANNKIND CORP
Sign in to watch- Ticker
- MNKD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 133607736
- Phone
- +1 818-661-5000
- Business address
- 1 CASPER STREET, DANBURY, CT, 06810
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Open-market buy EVP, Chief People Officer bought 14,124 shares at $1.77 ($24,999)
- 4/A Open-market buy Chief Medical Officer bought 2,824 shares at $1.77 ($4,998)
- 4/A Open-market buy Chief Commercial Officer bought 14,124 shares at $1.77 ($24,999)
- 4/A Open-market buy Chief Executive Officer bought 25,000 shares at $1.77 ($44,250)
- 4 Grant or award EVP Genl Counsel & Secretary acquired 43,616 shares (grant or award)
- 4 Grant or award Corp VP, Chief People Officer acquired 36,745 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 40,268 shares (grant or award)
- 4 Grant or award Corp VP, CTO acquired 38,507 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 37,026 shares (grant or award)
- 4 Grant or award Chief Marketing Officer acquired 11,871 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 40,268 shares (grant or award)
- 4 Grant or award Chief Compliance Officer acquired 12,584 shares (grant or award)
- 4 Grant or award SVP, Investor Relations acquired 18,484 shares (grant or award)
Page 18 of 50 · 999 filings